Skip to main content
. 2024 Jul 26;42(31):3680–3691. doi: 10.1200/JCO.23.02363

FIG A1.

FIG A1.

Flowchart of dose modification. aExcept for nausea, vomiting, diarrhea, constipation, or grade 3 and 4 nonhematologic toxicities that are considered manageable by the investigator. AE, adverse event.